# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Multiple sclerosis

MS
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 41-50 of 479 results.
Managed Access Program (MAP) for Patients Diagnosed With Secondary Progressive Multiple Sclerosis With Active Disease
Status: Available
Last Changed: Sep 09, 2020
First Received: Sep 07, 2020
Disease(s): Multiple Sclerosis
Intervention(s): Siponimod
MUltiple Sclerosis : T Cell / B Cell Exploration
Status: Recruiting
Last Changed: Jan 18, 2020
First Received: Jan 18, 2020
Disease(s): Multiple Sclerosis
Locations: Rennes University Hospital, Rennes, France
Simvastatin in Secondary Progressive Multiple Sclerosis
Status: Recruiting
Last Changed: Mar 30, 2020
First Received: Mar 29, 2019
Disease(s): Secondary Progressive Multiple Sclerosis
Intervention(s): Simvastatin
Locations: Department of Neuroinflammation, UCL Institute of Neurology, London, United Kingdom
NARCOMS Registry: A Multiple Sclerosis Registry
Status: Recruiting
Last Changed: May 13, 2020
First Received: Nov 23, 2009
Disease(s): Multiple Sclerosis
Locations: Washington University School of Medicine, Saint Louis, Missouri, United States
Meningeal Inflammation on 7T MRI as a Tool for Measuring and Predicting Ocrelizumab Response in Multiple Sclerosis
Status: Recruiting
Last Changed: Nov 10, 2020
First Received: Jan 11, 2018
Disease(s): Multiple Sclerosis
Intervention(s): Gadoteridol
Locations: University of Maryland School of Medicine, Baltimore, Maryland, United States
Lipoic Acid for Progressive Multiple Sclerosis (MS)
Status: Recruiting
Last Changed: Aug 06, 2020
First Received: May 19, 2017
Disease(s): Multiple Sclerosis
Intervention(s): Lipoic acid, Placebo
Locations: University of Alabama at Birmingham, Birmingham, Alabama, United States
University of Colorado, Aurora, Colorado, United States
Washington DC VA Medical Center, Washington, DC, Washington, District of Columbia, United States
VA Portland Health Care System, Portland, OR, Portland, Oregon, United States
VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas, Texas, United States
... and 7 other locations.
Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple Sclerosis
Status: Recruiting
Last Changed: Nov 04, 2020
First Received: Jul 21, 2020
Disease(s): Multiple Sclerosis
Intervention(s): Fingolimod
Locations: Novartis Investigative Site, Taipei, Taiwan
Disease Modifying Therapies Withdrawal in Inactive Secondary Progressive Multiple Sclerosis Patients Older Than 50 Years (STOP-I-SEP)
Status: Recruiting
Last Changed: Jun 22, 2020
First Received: Aug 31, 2018
Disease(s): Multiple Sclerosis
Intervention(s): DMT withdrawal, DMT continuation
Locations: CHU Angers, Angers, France
CHU Brest, Brest, France
CHU Clermont-Ferrand, Clermont-Ferrand, France
CHU Dijon, Dijon, France
CH Gonesse, Gonesse, France
... and 18 other locations.
Decision Making in Multiple Sclerosis Care Under Uncertainty
Status: Recruiting
Last Changed: Jul 29, 2019
First Received: Jul 29, 2019
Disease(s): Multiple Sclerosis
Intervention(s): Quantitative risk
Locations: St. Michael's Hospital, Toronto, Ontario, Canada
DreaMS - Digital Biomarkers for Multiple Sclerosis
Status: Recruiting
Last Changed: Oct 05, 2020
First Received: Jun 02, 2020
Disease(s): Multiple Sclerosis
Intervention(s): DreaMS
Locations: RC2NB, Basel, Switzerland